ArticleBiomedicines2021

Results of TETimaX Trial of Langerhans Cell Histiocytosis Treatment and Perspectives on the Role of Imatinib Mesylate in the Era of MAPK Signaling.

Liliana Montella et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.